Steve Chaplin
No ORCID on file
· 3 papers in corpus
· active 2009-2018
In September 2017, NICE published its first guidance specifically addressing the diagnosis and management of endometriosis (NG73). This article summarises the key recommendations of the new guidance.
Abstract Qlaira (estradiol valerate plus dienogest) is the first combined oral contraceptive to gain a licence for the treatment of heavy menstrual bleeding in women without organic pathology who desire oral contraception. In our New produc…
Abstract Qlaira is a new multiphasic COC that is taken continuously and comprises four combinations of estradiol valerate and the progestogen dienogest, plus two inert tablets. In our New products review, Steve Chaplin presents the clinical…